Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
8.80
+0.11 (1.27%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.59 billion as of July 17, 2026. Its market cap has increased by 89.33% in one year.
Market Cap
1.59B
Enterprise Value
1.74B
1-Year Change
89.33%
Ranking
Category
Stock Price
$8.80
ChartMarket Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.59B, an increase of 439.23%. That is a compound annual growth rate of 42.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 1.59B | 22.45% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 2.03B |
| Amylyx Pharmaceuticals | 1.89B |
| Bausch Health Companies | 1.84B |
| ANI Pharmaceuticals | 1.74B |
| Harrow | 1.67B |
| Trulieve Cannabis | 1.62B |
| Perrigo Company | 1.54B |
| Phibro Animal Health | 1.40B |